ACL is a listed company. Its directors and officers file their transactions with ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for ACL logged 9 filings by 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 9 filings in twelve months, the company is more active than the median of 3 filings across the 2,521 companies we follow on the same exchange.
Over the last twelve months, not one insider purchase of ACL stock was filed.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Analysts rate ACL Hold (neutral), based on 7 analysts. Average price target: A$2.79.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2025 · cache
9 of 9 declarations
ACL is a company listed on the XASX market, specializing in various financial services.
Insider filings
Over the last 90 days, 3 filings published between 31 August and 12 October 2026: no open-market purchase or sale filed by an insider. 3 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 15 October 2026 (UTC)